Pulmonary Hypertension

pulmonary stenosis and atresia :: Article Creator What Is Heart Disease? Everything You Need To Know DepositPhotos.Com What Is Heart Disease? Heart disease is a type of cardiovascular disease that affects the heart's structure and function. Several different heart conditions fall under the umbrella term for heart disease. The most common type is coronary artery disease, in which plaque builds up in the arteries and blocks blood flow to the heart, potentially leading to heart attacks or heart failure. According to the Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of death in the United States in men and women. Nearly 650,000 Americans die from heart disease annually. Young adults make up a growing percentage of cardiovascular disease events, with heart attack rates increasing by two percent every year in people under age forty. (Learn more about How to Lower Blood Pressure.) DepositPhotos.Com Ty

pulmonary vein stenosis symptoms in adults :: Article Creator RSV Can Be Deadly, Especially For Older Adults. What To Know About Symptoms And The New Vaccine First discovered in chimpanzees in 1956 and in children the following year, respiratory syncytial virus (RSV) isn't new. Neither is it uncommon among the youngest and oldest populations, infecting most babies and toddlers before their second birthday and accounting for the annual hospitalization of up to 160,000 U.S. Adults 60 and older. In recent years, however, COVID-19 has not only stolen the public health spotlight but also eclipsed the development of the first RSV vaccine. "[RSV] can be very risky, but people are not as aware of it as a virus in itself," Dr. Sujata Ambardar, an infectious disease specialist at Inova Fairfax Hospital in Falls Church, Va., tells Fortune. "They think of COVID, flu, and other viruses." Though Ambardar believes RSV awareness is on

chronic pulmonary lung disease :: Article Creator Viruses Can Hide In Lung Cells And Cause Chronic Disease Doctors have long known that children who become seriously ill with certain respiratory viruses, such as respiratory syncytial virus (RSV), are at elevated risk of developing asthma later in life. However, the reason why this happens has remained a mystery. A new study by researchers at Washington University School of Medicine in St. Louis may have solved this puzzle. Viruses linger in immune cells The study, conducted in mice, found that respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have disappeared. This lingering presence creates a persistently inflammatory environment that promotes the development of lung diseases like asthma. Moreover, the researchers demonstrated that eliminating these infected cells could reduce signs of chronic lung damage before they progress

collapsed lung treatment :: Article Creator Combined Valve Implantation Improves Severe Emphysema Outcomes Photo Credit: Mohammed Haneefa Nizamudeen Combining Zephyr and Spiration valve therapy benefited patients with COPD and advanced pulmonary emphysema while imparting a manageable risk profile. Endoscopic lung volume reduction using valves represents a minimally invasive approach for managing severe pulmonary emphysema. Among the available options, the Zephyr and Spiration valves are two distinct systems that can be implanted concurrently within the same procedure. In a study published in Respiratory Medicine, A. Susanne Dittrich, MD, and colleagues aimed to evaluate the impact of combined valve therapy on lung function, exercise capacity, and patient-reported outcomes for people with severe emphysema undergoing endoscopic lung volume reduction. "Previous studies focused on the outcome of either Zephyr or Spiration valve treatmen